PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosisPeng Du(Nanchang University), Xingjian Zhang(Nanchang University)International Journal of Medical SciencesJanuary 1, 202110.7150/ijms.62467Cited by 18SaveCiteExport RISWatch citationsRelated PapersLncRNA-XIST interacts with <i>miR-29c</i> to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway|Bioscience Reports|2017|116Metformin-Loaded Chitosan Hydrogels Suppress Bladder Tumor Growth in an Orthotopic Mouse Model via Intravesical Administration|Molecules|2023|9